Table 2. Number of patients with treatment-related adverse events by the dose level of KLS-1.
Adverse events/toxicity signs | Dose level (as per 64zinc) | |||
0.2 mg/kg (n) | 0.4 mg/kg (n) | 0.6 mg/kg (n) | 0.8 mg/kg (n) | |
Fatigue | 2 | 4 | 1 | - |
Weakness | 2 | 5 | 1 | 2 |
Dizziness | 2 | 3 | 1 | 2 |
Headache | 1 | - | - | - |
Chills | - | - | - | 1 |
Pain in the site of injection | - | - | - | 1 |
Poor sleep | - | - | 1 | 2 |
Nausea | - | - | 1 | 2 |
Abdominal discomfort | - | - | - | 2 |